This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...

By Andrew Silver SHANGHAI, Jan 14 (Reuters) - BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to ...

Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter.

Roche Diagnostics says it has developed blood tests to help rule out a diagnosis of Alzheimer’s disease in the broad population, thus narrowing who might be suffering from the disease. Nearly 7 ...

Roche (OTCQX:RHHBY) has obtained CE Mark for its pre-diluted VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx test. “The VENTANA HER2 (4B5) test now includes a scoring algorithm that helps ...

Roche says it's actively working with its partners to enhance mpox laboratory capacity worldwide to develop diagnostic tests to combat the outbreak. The World Health Organization (WHO) last week ...

ZURICH (Reuters) - Roche has struck a $1.7 billion cancer drug pact with Blueprint Medicines , it said on Tuesday, as advances in genetic testing for rare mutations drive lucrative deals for expensive ...